The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

NCT02592486 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Pneumococcal Pneumonia
Influenza

Interventions

BIOLOGICAL: Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®
BIOLOGICAL: Sequential administration of Pneumovax NP® and Fluvic HA syringe®

Sponsor

Kameda Medical Center

Collaborators

[object Object]
[object Object]
[object Object]